Security record · archived quarter
IMTX
Immatics N.V. · Healthcare · Biotechnology
8Tracked holders
—Δ holders
15.53MShares held
$176.70MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 35 | 0 | 11.76M | $118.95M | +4 | −4 |
| Q1 2026 | 35 | +3 | 20.34M | $199.85M | +5 | −2 |
| Q4 2025 | 31 | 0 | 13.12M | $137.78M | — | — |
| Q3 2025 | 11 | +1 | 6.87M | $58.55M | +2 | −1 |
| Q2 2025 | 7 | -1 | 7.51M | $36.14M | — | −1 |
| Q1 2025 | 7 | -3 | 10.10M | $41.98M | — | −3 |
| Q4 2024 | 10 | +1 | 14.90M | $100.53M | +2 | −1 |
| Q3 2024 | 8 | 0 | 16.54M | $184.94M | +1 | −1 |
| Q2 2024 | 8 | — | 15.53M | $176.70M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 9.54M | — | $110.82M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 9.54M | — | $110.82M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 9.54M | — | $110.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 9.54M | — | $110.82M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 9.54M | — | $110.82M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 3.64M | — | $42.29M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 885.41K | — | $10.29M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 885.41K | — | $10.29M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 751.25K | — | $8.73M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 218.70K | — | $1.77M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 218.70K | — | $1.77M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 110.22K | — | $1.28M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 330.02K | — | $854,760 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 58.37K | — | $678,201 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 82 holders, 108.05M shares, $842.81M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API